Article de revue
Sustaining GAVI-supported vaccine introductions in resource-poor countries
Since 2000, GAVI provided essential support for an unprecedented increase in the use of hepatitis B (HepB) and Haemophilus influenzae (Hib) containing vaccines in resource poor countries. This increase was supported with significant funding from international donors, intended to be time-limited. To assess the sustainability of this important expansion of the global access to vaccines, we reviewed supply chains, financial resources for procurement and decision-making in countries that introduced hepatitis B or Hib vaccines with GAVI support. During the period studied, the types of vaccine products supplied fluctuated rapidly in relationship with the number of suppliers and availability of more combination products. The price of the cheaper vaccines decreased while that of pentavalent DTwP-HepB-Hib remained stable. In average, vaccine introduction was associated with an increase of national programs budget, with new vaccines representing more than half of that increase, while the part of GAVI contributions to t
Auteurs
Langues
- Anglais
Année de publication
2011
Journal
Vaccine
Volume
17
Type
Article de revue
Catégories
- Chaîne d'approvisionnement
Mots-clés
- Distribution system
- New vaccine introduction
- Planning, budgeting and financing